Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers Reply

被引：0
|
作者：
Wright, Jean L. [1 ]
Rahbar, Habib [2 ]
Obeng-Gyasi, Samilia [3 ]
Carlos, Ruth [4 ]
Tjoe, Judy A. [5 ]
Wolff, Antonio [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Ohio State Univ, Columbus, OH 43210 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Novant Hlth, Greensboro, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 14期
关键词：
D O I：
10.1200/JCO.22.00220
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1595 / +
页数：2
相关论文
共 50 条
  • [1] Germline Pathogenic Variants in BRCA1 and BRCA2: Malignancies Beyond Female Breast and Ovarian Cancers
    Lieberman, Sari
    Goldvaser, Hadar
    Levy-Lahad, Ephrat
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (14) : 1590 - +
  • [2] Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer
    Foulkes, William D.
    Polak, Paz
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024,
  • [3] Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
    Ferreyra, Yomali
    Rosas, Gina
    Cock-Rada, Alicia M.
    Araujo, Jhajaira
    Bravo, Leny
    Doimi, Franco
    Casas, Jhoysi
    Clavo, Maria de los Angeles
    Pinto, Joseph A.
    Belmar-Lopez, Carolina
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
    Edaily, Sarah
    Abdel-Razeq, Hikmat
    [J]. ONCOTARGETS AND THERAPY, 2022, 15 : 815 - 826
  • [5] Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
    Phillips, Kelly-Anne
    Kotsopoulos, Joanne
    Domchek, Susan
    Chamberlain, James
    Bassett, Julie
    Aeilts, Amber
    Andrulis, Irene
    Buys, Saundra
    Cui, Wanda
    Daly, Mary
    Eisen, Andrea
    Foulkes, William
    Friedlander, Michael
    Gronwald, Jacek
    Hopper, John
    John, Esther
    Karlan, Beth
    Kim, Raymond
    Lubinski, Jan
    Metcalfe, Kelly
    Nathanson, Katherine
    Singer, Christian F.
    Symecko, Heather
    Tung, Nadine
    Narod, Steven
    Terry, Mary Beth
    Milne, Roger
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [6] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. LABORATORY INVESTIGATION, 2019, 99
  • [7] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    [J]. MODERN PATHOLOGY, 2019, 32
  • [8] Mathematical modeling for prediction of secondary BRCA1 and BRCA2 mutations in ovarian cancers with deleterious germline BRCA1 and BRCA2 mutations
    Botesteanu, Dana-Adriana
    Levy, Doron
    Lee, Jung-Min
    [J]. CANCER RESEARCH, 2016, 76
  • [9] Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
    Yunuo Zhang
    Heming Wu
    Zhikang Yu
    Liang Li
    Jinhong Zhang
    Xinhong Liang
    Qingyan Huang
    [J]. BMC Cancer, 22
  • [10] Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
    Zhang, Yunuo
    Wu, Heming
    Yu, Zhikang
    Li, Liang
    Zhang, Jinhong
    Liang, Xinhong
    Huang, Qingyan
    [J]. BMC CANCER, 2022, 22 (01)
12345